[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lyell Immunopharma Inc (LYEL)

Lyell Immunopharma Inc (LYEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lyell Immunopharma Inc 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 USA

www.lyell.com Employees: 161 P: 650-695-0677

Sector:

Medical

Description:

Lyell Immunopharma Inc. is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. Lyell Immunopharma Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 316,592
Enterprise Value, $K 256,412
Shares Outstanding, K 24,504
Float, K 22,985
% Float 93.80%
Short Interest, K 1,223
Short Float 4.99%
Days to Cover 3.44
Short Volume Ratio 0.82
% of Insider Shareholders 6.20%
% of Institutional Shareholders 66.05%

Financials:

Annual Sales, $ 40 K
Annual Net Income, $ -274,450 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -140,720 K
EBIT, $ -203,070 K
EBITDA, $ -196,490 K

Growth:

1-Year Return 39.83%
3-Year Return -78.03%
5-Year Return -95.54%
5-Year Revenue Growth -99.48%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.10 on 05/06/26
Next Earnings Date 08/11/26 [--]
Earnings Per Share ttm -16.30
EPS Growth vs. Prev Qtr 85.68%
EPS Growth vs. Prev Year 69.44%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 06/02/25

LYEL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -85.71%
Return-on-Assets % -66.41%
Profit Margin % -686,125.05%
Debt/Equity 0.00
Price/Sales 9,066.48
Price/Cash Flow N/A
Price/Book 1.18
Book Value/Share 11.69
Interest Coverage -5.18
60-Month Beta -0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.